Physician at MacKay Memorial Hospital, Taiwan
Professional Profile
Summary
Dr. Yueh-Hung Lin is a physician and board-certified cardiologist from Taiwan with extensive experience in coronary intervention, endovascular therapy (EVT), and cardiovascular imaging. He served at MacKay Memorial Hospital, where he was actively involved in diagnosing and treating complex cardiovascular conditions. Dr. Lin's clinical expertise spans both invasive and non-invasive techniques, with a strong focus on improving outcomes for patients with coronary and peripheral artery diseases. His work reflects a commitment to excellence in patient care, advanced imaging, and interventional cardiology.
Educational Details
Dr. Lin earned his Doctor of Medicine (M.D.) degree and is a board-certified cardiologist with specialization in coronary intervention, endovascular therapy (EVT), and cardiovascular imaging. His academic training emphasized both clinical proficiency and technical acumen, equipping him for a career that spans bedside cardiology and computational vascular modeling.
Professional Experience
Dr. Lin served as a physician and cardiovascular specialist at MacKay Memorial Hospital, where he led and collaborated on multiple research projects involving vascular imaging and interventional therapies. His work extended into computational domains, using clinical datasets to model blood flow dynamics and arterial networks. His practical expertise includes performing coronary and peripheral interventions and optimizing treatment protocols using imaging-derived analytics.
Research Interests
Dr. Lin's research focuses on the integration of clinical cardiology with network science, particularly through computed tomographic analysis, tissue composition studies, and muscle density evaluation. His work in cardiovascular network modeling has enabled new insights into disease progression, intervention planning, and vascular health monitoring. He leverages graph-theoretical approaches to simulate arterial structures and identify biomarkers in conditions like coronary artery disease (CAD) and peripheral artery disease (PAD).
Author Metrics
Dr. Lin maintains an active research presence on platforms such as ResearchGate, where his contributions to cardiovascular imaging, angiographic analysis, and vascular modeling are accessible. His publications reflect a growing academic impact in interdisciplinary cardiovascular research, with citations from both clinical and engineering domains.
Awards and Honors
Dr. Lin has been recognized for his pioneering work at the intersection of cardiology and data analytics. His awards and grants highlight contributions to innovation in vascular diagnostics, including support from institutional and national bodies. These accolades underscore his role as a forward-thinking clinician-researcher advancing the application of network science in healthcare.
Publication Top Notes
1. TwPAD Registry: A Prospective, Multicenter Registry of Chronic Peripheral Arterial Disease Involving Lower Limbs in Taiwan
Authors: Y.H. Lin, C.H. Hsu, J.K. Lee, P.C. Hsu, C.Y. Lee, C.C. Chen, P.W. Chen, H.P. Wu, et al.
Journal: Journal of the Chinese Medical Association, Vol. 88(5), pp. 389–397, 2025
Summary:
This multicenter registry highlights the epidemiological and clinical characteristics of chronic peripheral artery disease (PAD) in the Taiwanese population. Dr. Lin contributed to the design and implementation of this registry, which provides critical insights into PAD prevalence, risk stratification, and therapeutic patterns in East Asia.
2. Fluid Intake Impact on Heart Failure: Systematic Review and Meta-Analysis With Trial Sequential Analysis
Authors: S.M. Hsu, Y.H. Lin, Y.C. Lin, S.J. Liu, C.J. Liu, C.L. Hung, T.J. Wang
Journal: Journal of the Formosan Medical Association, 2024
Summary:
This study explores the impact of fluid intake on heart failure outcomes through a comprehensive meta-analysis and trial sequential analysis. Dr. Lin contributed clinical insights and data interpretation to inform fluid management guidelines for heart failure patients.
3. Preclinical Systolic Dysfunction Relating to Ankle-Brachial Index Among High-Risk PAD Population With Preserved Left Ventricular Ejection Fraction
Authors: Y.H. Lin, K.T. Sung, C.T. Tsai, Y.H. Lai, C.I. Lo, F.C. Yu, W.R. Lan, T.C. Hung, et al.
Journal: Scientific Reports, Vol. 14(1), Article 6145, 2024
Summary:
This study investigates the link between subtle systolic dysfunction and abnormal ankle-brachial index (ABI) in high-risk PAD patients. It underscores Dr. Lin's interest in early-stage cardiovascular dysfunction detection and his integrative research approach combining imaging and vascular markers.
4. Penalized Model-Based Unsupervised Phenomapping Unravels Distinctive HFrEF Phenotypes With Improved Outcomes Discrimination From Sacubitril/Valsartan Treatment
Authors: K.T. Sung, H.Y. Chang, N.W. Hsu, W.H. Huang, Y.H. Lin, C.H. Yun, C.C. Hsiao, et al.
Journal: Journal of the American Heart Association, Vol. 12(18), Article e028860, 2023
Summary:
Employing advanced machine learning and phenomapping, this research reveals distinctive phenotypes in heart failure with reduced ejection fraction (HFrEF). Dr. Lin contributed to the clinical framing and validation of predictive outcomes, helping identify patient subsets who benefit most from Sacubitril/Valsartan therapy.
5. Association of Region-Specific Cardiac Adiposity With Dysglycemia and New-Onset Diabetes
Authors: K.T. Sung, J.Y. Kuo, C.H. Yun, Y.H. Lin, J.P. Tsai, C.I. Lo, C.C. Hsiao, Y.H. Lai, et al.
Journal: Journal of the American Heart Association, Vol. 10(24), Article e021921, 2021
Summary:
This paper explores the association between cardiac fat deposition and dysglycemia progression. Dr. Lin played a significant role in the integration of imaging and metabolic data, highlighting how region-specific adiposity contributes to cardiometabolic disease development.
Conclusion
Dr. Yueh-Hung Lin stands out as an exceptionally qualified nominee for the Best Researcher Award in Cardiovascular Science. His blend of clinical insight, academic rigor, and impactful publication record demonstrates a strong commitment to advancing patient care through evidence-based and data-enhanced medicine. While there is room for further leadership visibility on a global platform, his existing achievements clearly position him as a deserving and promising recipient of this prestigious honor.